Gliclazide 60mg XR

Gliclazide 60mg XR is an extended-release oral antidiabetic medication commonly prescribed for the treatment and management of type 2 diabetes mellitus. It belongs to the sulfonylurea class of medicines and works by stimulating insulin secretion from the pancreas to help control blood glucose levels effectively. The XR (Extended Release) formulation gradually releases the medication throughout the day, supporting sustained glucose control and reducing blood sugar fluctuations.

Gliclazide 60mg XR is often recommended when lifestyle modifications such as healthy diet, exercise, and weight management alone are insufficient to maintain proper glycemic control. Long-term diabetes management is important for reducing complications involving the kidneys, nerves, eyes, and cardiovascular system.

Patients evaluating diabetes treatment options may also explore Gliclazide 30mg MR as a related modified-release therapy for physician-supervised blood sugar management.

Healthcare professionals frequently consult Mayo Clinic – Type 2 Diabetes Treatment and NHS – Gliclazide Overview for evidence-based diabetes care recommendations and updated medication safety guidance.

Mechanism of Action

Insulin Secretion Enhancement

Gliclazide 60mg XR stimulates pancreatic beta cells to release insulin, helping glucose move from the bloodstream into body tissues where it is utilized for energy.

Extended-Release Support

The XR formulation gradually delivers medication throughout the day, helping maintain stable blood sugar levels and improving overall glycemic control in patients with type 2 diabetes mellitus.

Patients comparing diabetes therapies may also evaluate Gliclazide 30mg MR for additional long-acting glucose management options under healthcare supervision.

Approved Medical Uses

Type 2 Diabetes Mellitus

Gliclazide 60mg XR is primarily prescribed for adults with type 2 diabetes mellitus who require additional blood sugar control beyond lifestyle modifications alone.

Combination Therapy

The medication may be used alone or alongside other antidiabetic medicines depending on individual patient treatment requirements.

Dosage and Administration

Standard Dosage

The dosage should always be determined by a healthcare provider based on blood glucose levels, treatment response, and overall medical condition. Tablets are generally taken with breakfast or the first meal of the day.

Importance of Regular Meals

Maintaining regular meals and blood sugar monitoring is important during treatment to reduce the risk of hypoglycemia.

Missed Dose Instructions

If a dose is missed, it should be taken when remembered unless it is close to the next scheduled dose. Double dosing should be avoided.

Clinical Effectiveness

Clinical studies have demonstrated that Gliclazide 60mg XR effectively lowers blood glucose and HbA1c levels in patients with type 2 diabetes mellitus. Sustained glucose control may help reduce the risk of long-term diabetic complications and improve overall metabolic health.

Healthcare providers may recommend therapies such as Gliclazide 30mg MR alongside personalized diabetes management strategies depending on patient-specific treatment goals.

Safety and Side Effects

Common Side Effects

Some commonly reported side effects include:

• Low blood sugar (hypoglycemia)
• Dizziness
• Headache
• Nausea
• Mild weight gain

  FAQs